Last Update 11 Dec 25
AIP: Expanded AI Wins Will Likely Fail To Justify Rich Expectations
Analysts have modestly raised their price target on Arteris to approximately $17.13 per share. This reflects slightly higher long term margin expectations and a marginally improved growth and risk profile.
What's in the News
- Raised full year 2025 revenue guidance to a range of $68.8 million to $69.2 million, reflecting improved visibility into demand (company guidance)
- Issued fourth quarter 2025 revenue guidance of $18.4 million to $18.8 million, providing investors with a near-term outlook on the growth trajectory (company guidance)
- Expanded collaboration with Alibaba DAMO Academy's XuanTie RISC V CPU IP to deliver pre-verified SoC reference designs targeting edge AI, server, communications, and automotive applications (client announcement)
- Secured multiple FlexNoC 5 and Ncore 3 IP licensing wins with AI- and data center-focused customers including Axelera AI, Blaize, Black Sesame Technologies, and 2V Systems, underscoring adoption in high performance compute and autonomous driving markets (client announcements)
- Won FlexGen smart NoC IP design-in with NanoXplore for radiation-hardened, space-focused FPGA platforms, extending reach into mission-critical aerospace and defense applications (client announcement)
Valuation Changes
- Fair Value: Unchanged at approximately $17.13 per share, indicating a stable central valuation view.
- Discount Rate: Risen slightly from about 8.42 percent to 8.49 percent, reflecting a modestly higher perceived risk profile.
- Revenue Growth: Essentially unchanged at roughly 19.47 percent, suggesting consistent long term top line expectations.
- Net Profit Margin: Risen slightly from about 12.38 percent to 12.42 percent, pointing to a marginal improvement in long term profitability assumptions.
- Future P/E: Edged down slightly from about 83.13 times to 83.01 times, signaling a very small reduction in the implied valuation multiple.
Key Takeaways
- Rising AI adoption and industry shifts toward chiplet architectures are expanding Arteris' market opportunities and supporting sustained revenue growth.
- Innovative product launches and stronger customer reliance are boosting competitive advantage, recurring revenues, and margin expansion potential.
- Dependence on large customers, rising R&D costs, and evolving industry dynamics threaten revenue stability, profitability, and long-term growth amid ongoing macroeconomic uncertainties.
Catalysts
About Arteris- Provides semiconductor system intellectual property solutions in the United States, rest of the Americas, China, Korea, the rest of the Asia Pacific, Europe, and the Middle East.
- Accelerating adoption of AI and machine learning in enterprise computing and automotive sectors is driving higher demand for Arteris' advanced NoC IP, as evidenced by recent major wins like AMD and Whalechip; this is likely to underpin sustained revenue growth as AI workloads and system complexity proliferate across industries.
- The ongoing industry transition to chiplet-based and heterogeneous integration architectures is expanding Arteris' addressable market, with chiplet-related design starts expected to rise from 5% to 30% in coming years; this structural trend supports both higher sales volume and increased average selling prices, benefiting future top-line revenue.
- Arteris' launch of innovative products such as FlexGen and Magillem Packaging-recognized with industry awards and integrated into leading chipmaker portfolios-raises the technological moat, improving competitive positioning and enabling potential margin expansion through pricing power.
- Increasing reliance by large semiconductor companies on outsourcing specialized system IP, highlighted by growing customer interest and accelerated engagements, suggests expanding recurring revenue streams and enhanced revenue visibility, which may drive more stable and predictable long-term earnings.
- Growth in remaining performance obligations (RPO), up 28% year-over-year, signals a solid and expanding contractual revenue base, providing confidence in forward revenue realization and supporting operating leverage as R&D investments start to scale with increased deployment of Arteris' solutions.
Arteris Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?- Analysts are assuming Arteris's revenue will grow by 17.7% annually over the next 3 years.
- Analysts are not forecasting that Arteris will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate Arteris's profit margin will increase from -52.4% to the average US Software industry of 13.1% in 3 years.
- If Arteris's profit margin were to converge on the industry average, you could expect earnings to reach $13.5 million (and earnings per share of $0.26) by about September 2028, up from $-33.1 million today.
- In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 67.4x on those 2028 earnings, up from -11.4x today. This future PE is greater than the current PE for the US Software industry at 36.6x.
- Analysts expect the number of shares outstanding to grow by 6.15% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 8.46%, as per the Simply Wall St company report.
Arteris Future Earnings Per Share Growth
Risks
What could happen that would invalidate this narrative?- Arteris continues to operate at a net loss and projects a non-GAAP operating loss for the full year 2025 ($10.5 to $15.5 million), indicating ongoing challenges in achieving profitability and potential pressure on earnings and net margins if revenue growth falters or costs escalate.
- The high concentration of large whale deals (such as the recent AMD agreement) exposes Arteris to customer concentration risk; if major customers reduce outsourcing, insource NoC IP, or switch providers, future revenues and cash flows could become volatile.
- The increasing scale of R&D and field engineering investments, combined with only a gradual ramp in new product adoption, raises the risk that operating costs will outpace revenue growth, which could further suppress margins and delay a path to sustainable earnings.
- The expansion of chiplet and heterogeneous integration technologies by mega-customers (like AMD using its own Infinity Fabric for coherent data, and only using Arteris for non-coherent applications) could lead to competitors or major chipmakers developing proprietary NoC solutions, diminishing Arteris' external market and negatively impacting long-term revenue growth.
- Macroeconomic uncertainty (including FX fluctuations, global economic conditions, and possible geopolitical headwinds) can impact deal flow, OpEx (as seen recently with unfavorable USD/EUR movements), and delay sales cycles, all of which add risk to revenue predictability and margin expansion over time.
Valuation
How have all the factors above been brought together to estimate a fair value?- The analysts have a consensus price target of $14.0 for Arteris based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $16.0, and the most bearish reporting a price target of just $11.0.
- In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $103.2 million, earnings will come to $13.5 million, and it would be trading on a PE ratio of 67.4x, assuming you use a discount rate of 8.5%.
- Given the current share price of $8.83, the analyst price target of $14.0 is 36.9% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Arteris?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.



